Erratum: Power and limits of modern cancer diagnostics: Cancer of unknown primary [Ann Oncol, 23, (2012), (760-764)] doi:10.1093/annonc/mdr369;Power and limits of modern cancer diagnostics: Cancer of unknown primary

Annals of Oncology

Volumn 23, Issue 3, 2012, Pages 760-764

  Hemminki, K ^a,b   Liu, H ^a   Heminki, A ^c   Sundquist, J ^b,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer of unknown primary; Modern diagnostics; Relative risks

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER; SENSITIVITY ANALYSIS; SWEDEN; TREND STUDY; WHOLE BODY CT;

EID: 84863244155     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdx057     Document Type: Erratum

References (21)

1. Randen M, Rutqvist LE, Johansson H. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007. Acta Oncol 2009; 48: 915-920.
2. Morris GJ, Greco FA, Hainsworth JD et al. Cancer of unknown primary site. Semin Oncol 2010; 37: 71-79.
3. Pavlidis N, Briasoulis E, Pentheroudakis G. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl 5): v228-v231.
4. Frangioni J. New technologies for human cancer imaging. J Clin Oncol 2008; 26: 4012-4021.
5. Abbruzzese JL, Abbruzzese MC, Lenzi R et al. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13: 2094-2103.
6. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004; 100: 1776-1785.
7. Jonsson E, Banta HD. Health care technology in Sweden. Health Policy 1994; 30: 257-294.
8. Jonsson E, Banta H, Schersten T. Health technology assessment and screening in Sweden. Int J Technol Assess Health Care 2001; 17: 380-388.
9. Carlsson P, Jonsson E, Werko L, Banta D. Health technology assessment in Sweden. Int J Technol Assess Health Care 2000; 16: 560-575.
10. Freudenberg LS, Rosenbaum-Krumme SJ, Bockisch A et al. Cancer of unknown primary. Recent Results Cancer Res 2008; 170: 193-202.
11. Kwee TC, Basu S, Alavi A. PET and PET/CT for unknown primary tumors. Methods Mol Biol 2011; 727: 317-333.
12. Centre for Epidemiology. Cancer Incidence in Sweden 2005. Stockholm, Sweden: The National Board of Health and Welfare 2007.
13. Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med 2010; 134: 216-224.
14. Pavlidis N, Fizazi K. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 2009; 69: 271-278.
15. Shu X, Liu H, Ji J et al. Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights? Ann Oncol 2012; 23: 269-275.
16. Hemminki K, Ji J, Sundquist J, Shu X. Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol 2011; 29: 435-440.
17. Dong C, Hemminki K. Second primary neoplasms in 633964 cancer patients in Sweden, 1958-1996. Int J Cancer 2001; 93: 155-161.
18. Frödin J-E, Ericsson J, Barlow L. Multiple primary malignant tumors in a national cancer registry. Reliability of reporting. Acta Oncol 1997; 36: 465-469.
19. Lindstrom P, Janzon L, Sternby NH. Declining autopsy rate in Sweden: a study of causes and consequences in Malmo, Sweden. J Intern Med 1997; 242: 157-165.
20. Blaszyk H, Hartmann A, Bjornsson J. Cancer of unknown primary: clinicopathologic correlations. APMIS 2003; 111: 1089-1094.
21. Pentheroudakis G, Greco FA, Pavlidis N. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review. Cancer Treat Rev 2009; 35: 221-227.